Demystifying Select Medical Hldgs: Insights From 4 Analyst Reviews
Demystifying Select Medical Hldgs: Insights From 4 Analyst Reviews
分析师对医疗控股公司Select Medical进行了4次评估，揭示了更多信息。
Throughout the last three months, 4 analysts have evaluated Select Medical Hldgs (NYSE:SEM), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中，有4位分析师对Select Medical Hldgs（纽约证券交易所代码：SEM）进行了评估，提供了从看涨到看跌的不同观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $44.5, a high estimate of $48.00, and a low estimate of $40.00. This upward trend is apparent, with the current average reflecting a 7.88% increase from the previous average price target of $41.25.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标价为44.5美元，最高估计为48.00美元，低估值为40.00美元。这种上升趋势显而易见，当前的平均价格较之前的平均目标价41.25美元上涨了7.88％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The perception of Select Medical Hldgs...
通过分析师最...
登录免费看全文
登录/注册